Reporter brief
Linum strictum seed oil showed α-amylase inhibition comparable to acarbose in in vitro testing.
What happened
This in vitro study characterized the fatty acid composition of Linum strictum seed oil and tested its biological activities. The oil's α-amylase inhibition reached 85.98% with an IC50 of 0.0134 mg/mL, which the authors report as comparable to acarbose. The study also found antibacterial activity against several strains, >70% biofilm inhibition against A. baumannii, and anticoagulant effects.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
In vitro; In vitro.
Linum strictum seed oil extracted from commercially obtained seeds; tested against bacterial strains including Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter baumannii, and Enterococcus faecalis ATCC 29212
- Design
- In vitro
- Sample
- —
- Journal
- Chemistry & Biodiversity
- Published
- Sep 1, 2026
Effect size
Antibacterial: MIC = 1.25 mg/mL (against E. faecalis ATCC 29212 and A. baumannii strains A2553 and A722); MIC = 5 mg/mL (S. aureus strains). Biofilm inhibition: >70% against A. baumannii at 2×MIC. Anticoagulant: PT = 16.4 s; aPTT = 81.6 s. α-Amylase inhibition: 85.98% (IC50 = 0.0134 mg/mL)
Caveats
- Assessment: Pending.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Acarbose timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.